Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 112 results for "novartis india"

Novartis India Q1 net profit falls 6% to Rs 13.45 crore
Money Control

Novartis India posts results for quarter ended June 30, 2015

The company registered net profit after other income of Rs 13.5 crore The Board of Novartis India approved the results for the quarter ended June 30, 2015. During the period under review, total income from operations was Rs 224.1 crore as ... Financial Express, 1 week ago
India Infoline

Novartis, India face off over patent-protection future there

It is the moment of truth for Novartis ($NVS) and its widely watched patent fight with India. But while this case is over its groundbreaking cancer treatment Gleevec, it will define what kind of intellectual property world drug companies will face ...
 FiercePharma3 days ago Novartis India informs about Standalone Financial Results  Finalaya.com1 week ago Novartis India, Elanco extend animal health biz closure date  Business Standard3 weeks ago Novartis India informs about Slump sale of Animal Health Division  Finalaya.com3 weeks ago

Novartis India standalone net profit declines 6.01% in the June 2015 quarter

Sales rise 6.89% to Rs 215.99 crore
 Business Standard1 week ago Novartis India standalone Mar '15 sales at Rs 207.64 crore  Money Control2 months ago

Results to watch out for: Alstom India, JSW Energy

We encourage visitors to register on IIFL. Registering on the site is absolutely Free and offers you the following benefits. Free Portfolio of Equity and Assets Exclusive E-newsletter Post Comments and Share Feedback Your Personal Page Access Premium Services ...
 India Infoline1 week ago Results to watch out for: Bharti Infratel, KPIT Technologies  India Infoline1 week ago
Business Today India

Novartis India denies delisting plans; stock plunges 13%

The stock had ended 15.72 per cent in previous trade following media reports that “Novartis AG was planning to delist Indian units.
 Economic Times1 month ago Twelve stocks in focus in Monday's trade  Economic Times2 weeks ago Novartis India shares tank on news of delisting from BSE  Business Today India1 month ago Novartis down 13% as it denies delisting plans  Economic Times1 month ago

Novartis India to hold board meeting

On 22 July 2015
 Business Standard2 weeks ago AGM on July 23, 2015 (SCRIPCODE: 500672)  HT Syndication1 month ago Novartis India to consider dividend on May 27, 2015  Money Control2 months ago
Money Control

Novartis, Aurobindo Pharma rise 2-4% on USFDA approvals

Novartis India has received the approval from USFDA for its heart failure treatment tablets LCZ696. "The drug is now called Entresto, approved by FDA to reduce risk of cardiovascular death and heart failure hospitalisation," said the company in its note.
 Money Control3 weeks ago Novartis gets USFDA nod for heart failure drug  Business Standard3 weeks ago Novartis advances on receiving USFDA nod for heart failure drug  Finalaya.com3 weeks ago

Novartis AG (ADR) (NVS) Delisting Rumors Of Its $419 Million Indian Arm Denied

Novartis AG ( NYSE:NVS ) is considering to delist its Indian operations, according to Bloomberg , which cited people close to the matter. In a statement released after-hours today, Novartis India Ltd., which has a current market value of $419 ...
 Bidness Etc1 month ago Novartis might delist $419-million Indian arm  Smart Investor1 month ago Novartis Said to Explore Delisting of $380 Million Indian Unit  Bloomberg1 month ago

USFDA approves Novartis' heart failure drug [Mumbai] [Times of India]

MUMBAI: Novartis announced the US Food and Drug Administration (FDA) approval of a heart failure drug, LCZ696 (sacubitril/valsartan) tablets. LCZ696 will be available on prescription for patients whose condition is classified NYHA class II-IV, ...
 Pharmacy Choice2 weeks ago

Three Indian students to participate in International Novartis BioCamp

Two aspiring doctors Pavithra Krishnan from Rajarajeswari Medical College and Hospital, Bengaluru and Manthan Mehta from Topiwala National Medical College and BYL Nair Charitable Hospital, Mumbai along with Sharmishtha Sharma of the India School of ...
 PharmaBiz2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less